Drug interactions

Amiodarone + Azithromycin

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Overview

Severity: Major · Evidence level: Moderate

Additive QTc prolongation with increased risk of torsades de pointes and serious ventricular arrhythmias; risk amplified by bradycardia or electrolyte abnormalities.

Mechanism of action

Pharmacodynamic: both agents prolong cardiac repolarization (Ikr/hERG blockade), increasing QTc; no clinically meaningful CYP-mediated PK interaction expected.

Clinical management

Avoid combination if possible; consider a non–QT-prolonging antibiotic. If unavoidable: obtain baseline and follow-up ECGs, maintain K >4 mEq/L and Mg >2 mg/dL, avoid other QT-prolonging drugs, consider telemetry in high-risk patients, and discontinue if QTc >500 ms or increases >60 ms.

Drug reference

References

  • Zithromax (azithromycin) Prescribing Information — FDA Label
  • Amiodarone hydrochloride (Cordarone/Pacerone) Prescribing Information — FDA Label
  • Azithromycin: Drug Interactions — Lexicomp
  • Amiodarone: Drug Interactions — Lexicomp

Frequently asked questions

Can I take Amiodarone with Azithromycin?

The interaction is rated: Major. Additive QTc prolongation with increased risk of torsades de pointes and serious ventricular arrhythmias; risk amplified by bradycardia or electrolyte abnormalities.

How serious is the interaction between Amiodarone and Azithromycin?

The interaction is rated: Major. Evidence level: Moderate.

How is the interaction between Amiodarone and Azithromycin managed?

Avoid combination if possible; consider a non–QT-prolonging antibiotic. If unavoidable: obtain baseline and follow-up ECGs, maintain K >4 mEq/L and Mg >2 mg/dL, avoid other QT-prolonging drugs, consider telemetry in high-risk patients, and discontinue if QTc >500 ms or increases >60 ms.

Why do Amiodarone and Azithromycin interact?

Pharmacodynamic: both agents prolong cardiac repolarization (Ikr/hERG blockade), increasing QTc; no clinically meaningful CYP-mediated PK interaction expected.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions